Underlying Science
The science behind our platform
Our health economic models are built on rigorous scientific methodology, incorporating state-of-the-art techniques in health economics and outcomes research. We utilize Markov models, discrete event simulation, and microsimulation approaches to accurately capture patient journeys and treatment pathways. Our models are validated against real-world data and published literature to ensure credibility with HTA bodies and payer organizations worldwide.
Our solutions are specifically developed for the application type of your product. We offer applications for diagnostic products such as blood tests and medical imaging, prognostic products including predictive algorithms, companion diagnostics, and therapeutics.
Diagnostics encompasses a range of technologies and tools designed to detect and monitor diseases.
Prognostics involves the use of technologies and algorithms to predict the likely course and outcome of diseases.
Companion diagnostics are specialized tests that identify patients most likely to benefit from specific treatments, enabling personalized therapies.
Treatment sequencing strategically orders therapies to maximize efficacy, reduce side effects, and improve patient outcomes.
Talk to an expert
Discuss your value story with Medip Analytics
Get a practical walkthrough of how to demonstrate clinical, operational, and economic value for diagnostic AI, medtech, biotech, and pharma products.
Products
Designed to help you maximize the value of your diagnostic, prognostic, or companion diagnostic product.
Medip Analytics offers a cost-effectiveness evaluation service for your diagnostic, prognostic, or companion diagnostic product across any disease area.
Database and analysis of cost data from US hospitals. Search for healthcare costs based on CPT-code.
Our consultancy services are designed to assist companies with all health economic questions. We leverage our scientific expertise and extensive experience to advise you on your health economic strategy.
